Sunteck Realty Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:01 pm

Quick Insight

Sunteck Realty Ltd's current market dynamics reveal a price of ₹389 with a market capitalization of ₹5,696 Cr., translating to a P/E ratio of 35.4. Despite a modest ROE of 4.71% and ROCE of 6.28%, the company maintains a healthy OPM of 25%. With substantial promoter ownership at 63.25% and institutional investor interest, the stock shows stability. The company's reserves stand at ₹3,245 Cr., with manageable borrowings of ₹387 Cr. Sunteck's P/BV ratio of 1.74x and ICR of 5.76x reflect a balanced financial structure, suggesting potential for growth with prudent risk management.

Competitors of Sunteck Realty Ltd

All Competitor Stocks of Sunteck Realty Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:55 am

Below is a detailed analysis of the quarterly data for Sunteck Realty Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 188.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 188.00 Cr., marking a decrease of 18.00 Cr..
• For Expenses, as of Jun 2025, the value is 141.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 137.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 4.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 21.00 Cr..
• For OPM %, as of Jun 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 33.00% (Mar 2025) to 25.00%, marking a decrease of 8.00%.
• For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For Interest, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 24.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 22.00%, marking a decrease of 3.00%.
• For Net Profit, as of Jun 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2025) to 33.00 Cr., marking a decrease of 17.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.28. The value appears to be declining and may need further review. It has decreased from 3.44 (Mar 2025) to 2.28, marking a decrease of 1.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:56 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:16 pm

Below is a detailed analysis of the balance sheet data for Sunteck Realty Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,245.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,110.00 Cr. (Mar 2024) to 3,245.00 Cr., marking an increase of 135.00 Cr..
• For Borrowings, as of Mar 2025, the value is 387.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 375.00 Cr. (Mar 2024) to 387.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,680.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,419.00 Cr. (Mar 2024) to 4,680.00 Cr., marking an increase of 261.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 8,327.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,918.00 Cr. (Mar 2024) to 8,327.00 Cr., marking an increase of 409.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 499.00 Cr.. The value appears strong and on an upward trend. It has increased from 490.00 Cr. (Mar 2024) to 499.00 Cr., marking an increase of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 14.00 Cr..
• For Investments, as of Mar 2025, the value is 235.00 Cr.. The value appears strong and on an upward trend. It has increased from 230.00 Cr. (Mar 2024) to 235.00 Cr., marking an increase of 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 7,561.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,179.00 Cr. (Mar 2024) to 7,561.00 Cr., marking an increase of 382.00 Cr..
• For Total Assets, as of Mar 2025, the value is 8,327.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,918.00 Cr. (Mar 2024) to 8,327.00 Cr., marking an increase of 409.00 Cr..

Notably, the Reserves (3,245.00 Cr.) exceed the Borrowings (387.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Sunteck Realty Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.26. This value is within the healthy range. It has increased from 4.99 (Mar 24) to 10.26, marking an increase of 5.27.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.26. This value is within the healthy range. It has increased from 4.99 (Mar 24) to 10.26, marking an increase of 5.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.01. This value is within the healthy range. It has increased from 5.49 (Mar 24) to 11.01, marking an increase of 5.52.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.54. It has increased from 213.28 (Mar 24) to 222.54, marking an increase of 9.26.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.54. It has increased from 213.28 (Mar 24) to 222.54, marking an increase of 9.26.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 58.24. It has increased from 38.56 (Mar 24) to 58.24, marking an increase of 19.68.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 16.07. This value is within the healthy range. It has increased from 11.79 (Mar 24) to 16.07, marking an increase of 4.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.19. This value is within the healthy range. It has increased from 11.14 (Mar 24) to 15.19, marking an increase of 4.05.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.40. This value is within the healthy range. It has increased from 6.48 (Mar 24) to 12.40, marking an increase of 5.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.14. This value is within the healthy range. It has increased from 4.83 (Mar 24) to 10.14, marking an increase of 5.31.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.26. This value is within the healthy range. It has increased from 4.84 (Mar 24) to 10.26, marking an increase of 5.42.
• For PBDIT Margin (%), as of Mar 25, the value is 27.58. This value is within the healthy range. It has decreased from 30.58 (Mar 24) to 27.58, marking a decrease of 3.00.
• For PBIT Margin (%), as of Mar 25, the value is 26.07. This value exceeds the healthy maximum of 20. It has decreased from 28.89 (Mar 24) to 26.07, marking a decrease of 2.82.
• For PBT Margin (%), as of Mar 25, the value is 21.28. This value is within the healthy range. It has increased from 16.79 (Mar 24) to 21.28, marking an increase of 4.49.
• For Net Profit Margin (%), as of Mar 25, the value is 17.40. This value exceeds the healthy maximum of 10. It has increased from 12.53 (Mar 24) to 17.40, marking an increase of 4.87.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 17.61. This value is within the healthy range. It has increased from 12.55 (Mar 24) to 17.61, marking an increase of 5.06.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.61. This value is below the healthy minimum of 15. It has increased from 2.27 (Mar 24) to 4.61, marking an increase of 2.34.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.46. This value is below the healthy minimum of 10. It has increased from 4.79 (Mar 24) to 6.46, marking an increase of 1.67.
• For Return On Assets (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 5. It has increased from 0.89 (Mar 24) to 1.80, marking an increase of 0.91.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.04, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.10. It has increased from 0.07 (Mar 24) to 0.10, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has decreased from 1.53 (Mar 24) to 1.50, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 1. It has increased from 0.20 (Mar 24) to 0.22, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.04, marking an increase of 0.04.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 29.70 (Mar 24) to 0.00, marking a decrease of 29.70.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 26.18 (Mar 24) to 0.00, marking a decrease of 26.18.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 70.30 (Mar 24) to 0.00, marking a decrease of 70.30.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 73.82 (Mar 24) to 0.00, marking a decrease of 73.82.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.76. This value is within the healthy range. It has increased from 2.53 (Mar 24) to 5.76, marking an increase of 3.23.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.63. This value is within the healthy range. It has increased from 2.04 (Mar 24) to 4.63, marking an increase of 2.59.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,846.22. It has decreased from 5,969.67 (Mar 24) to 5,846.22, marking a decrease of 123.45.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.85. This value exceeds the healthy maximum of 3. It has decreased from 10.57 (Mar 24) to 6.85, marking a decrease of 3.72.
• For EV / EBITDA (X), as of Mar 25, the value is 24.84. This value exceeds the healthy maximum of 15. It has decreased from 34.56 (Mar 24) to 24.84, marking a decrease of 9.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.64. This value exceeds the healthy maximum of 3. It has decreased from 10.09 (Mar 24) to 6.64, marking a decrease of 3.45.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 70.29 (Mar 24) to 0.00, marking a decrease of 70.29.
• For Price / BV (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.82 (Mar 24) to 1.74, marking a decrease of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.64. This value exceeds the healthy maximum of 3. It has decreased from 10.09 (Mar 24) to 6.64, marking a decrease of 3.45.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness